Form 4: Renovaro Inc. Director Rene Sindlev Acquires Options to Purchase 62,112 Shares
SEC Form 4
Director Rene Sindlev reports acquisition of options to purchase 62,112 shares of Renovaro Inc. common stock.
Summary
- On June 25, 2024, Rene Sindlev, a director and 10% owner of Renovaro Inc. (RENB), acquired options to purchase 62,112 shares of common stock.
- The exercise price of the options is $1.61.
- The options are exercisable immediately and expire on June 25, 2034.
- The options were acquired indirectly through RS Bio ApS.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The acquisition of options by a director could be viewed positively by shareholders as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/25/2024 | Date of transaction: acquisition of options to purchase shares of common stock |
| 06/25/2024 | Options become exercisable |
| 06/25/2034 | Options expiration date |
| 06/27/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.